Reciprocal regulation of activating and inhibitory Fcγ receptors by TLR7/8 activation: Implications for tumor immunotherapy

Clinical Cancer Research

Volumn 16, Issue 7, 2010, Pages 2065-2075

  Butchar, Jonathan P ^a   Mehta, Payal ^b   Justiniano, Steven E ^a   Guenterberg, Kristan D ^c   Kondadasula, Sri Vidya ^c   Mo, Xiaokui ^b   Chemudupati, Mahesh ^b   Kanneganti, Thirumala Devi ^d   Amer, Amal ^b   Muthusamy, Natarajan ^c   Jarjoura, David ^b   Marsh, Clay B ^a   Carson III, William E ^c   Byrd, John C ^c   Tridandapani, Susheela ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FCGAMMA RECEPTOR IIIB; RESIQUIMOD; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; INCUBATION TIME; MACROPHAGE; MICROARRAY ANALYSIS; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOLID TUMOR; WESTERN BLOTTING;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTINEOPLASTIC AGENTS; CYTOKINES; HUMANS; IMIDAZOLES; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS; RECEPTORS, IGG; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8; TUMOR CELLS, CULTURED;

EID: 77950670280     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2591     Document Type: Article

References (48)

1. Anderson CL, Shen L, Eicher DM, Wewers MD, Gill JK. Phagocytosis mediated by three distinct Fc γ receptor classes on human leukocytes. J Exp Med 1990;171:1333-1345
2. Casado JA, Merino J, Cid J, Subira ML, Sanchez-Ibarrola A. The type of interaction with Fc γ R in human monocytes determines the efficiency of the generation of oxidative burst. Immunology 1994;83:148-154
3. Kindt GC, Moore SA, She ZW, Wewers MD. Endotoxin priming of monocytes augments Fc γ receptor cross-linking-induced TNF-α and IL-1 β release. Am J Physiol 1993;265:L178-85.
4. Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat Med 2000;6:443-446
5. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. FcR γ chain deletion results in pleiotrophic effector cell defects. Cell 1994;76:519-529
6. Cooper PH, Mayer P, Baggiolini M. Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: correlation with biochemical and functional parameters. J Immunol 1984;133:913-922
7. Ralph P, Nakoinz I. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. J Immunol 1977;119:950-954
8. van Ojik HH, Bevaart L, Dahle CE, et al. CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations. Cancer Res 2003;63:5595-5600
9. Sidky YA, Borden EC, Weeks CE, et al. Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine. Cancer Res 1992;52:3528-3533
10. Schon MP, Schon M. TLR7 and TLR8 as targets in cancer therapy. Oncogene 2008;27:190-199
11. Miller RL, Meng TC, Tomai MA. The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect 2008;21:69-87.
12. Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 2002;27:571-577
13. Joshi T, Ganesan LP, Cao X, Tridandapani S. Molecular analysis of expression and function of hFcaγRIIbl and b2 isoforms in myeloid cells. Mol Immunol 2006;43:839-850
14. Butchar JP, Cremer TJ, Clay CD, et al. Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS One 2008;3:e2924.
15. Muehlbauer SM, Evering TH, Bonuccelli G, et al. Anthrax lethal toxin kills macrophages in a strain-specific manner by apoptosis or caspase-1-mediated necrosis. Cell Cycle 2007;6:758-766
16. Lamkanfi M, Moreira LO, Makena P, et al. Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival. Blood 2009;113:2742-2745
17. Dudoit S, Gentleman RC, Quackenbush J. Open source software for the analysis of microarray data. Biotechniques 2003:45-51.
18. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
19. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article3.
20. Johnson AJ, Wagner AJ, Cheney CM, et al. Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia. Br J Haematol 2007;139:837-844
21. Roda JM, Parihar R, Lehman A, et al. Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol 2006;177:120-129
22. Penichet ML, Challita PM, Shin SU, et al. In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice. Lab Anim Sci 1999;49:179-188
23. Tomai MA, Gibson SJ, Imbertson LM, et al. Immunomodulating and antiviral activities of the imidazoquinoline S-28463. Antiviral Res 1995;28:253-264
24. Poplack DG, Bonnard GD, Holiman BJ, Blaese RM. Monocytemediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. Blood 1976;48:809-816
25. Shaw GM, Levy PC, LoBuglio AF. Human monocyte cytotoxicity to tumor cells. I. Antibody-dependent cytotoxicity. J Immunol 1978;121:573-578
26. Catalona WJ, Ratliff TL, McCool RE. aγ-Interferon induced by S. aureus protein A augments natural killing and ADCC. Nature 1981;291:77-79
27. Weiner LM, Steplewski Z, Koprowski H, et al. Biologic effects of aγ interferon pre-treatment followed by monoclonal antibody 17-1A administration in patients with gastrointestinal carcinoma. Hybridoma 1986;5:S65-77.
28. Shen L, Guyre PM, Fanger MW. Direct stimulation of ADCC by cloned γ interferon is not ablated by glucocorticoids: studies using a human monocyte-like cell line (U-937). Mol Immunol 1984;21:167-173
29. Zhang M, Zhang Z, Garmestani K, et al. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia. Cancer Res 2004;64:5825-5829
30. Hemmi H, Kaisho T, Takeuchi O, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002;3:196-200.
31. Kanneganti TD, Ozoren N, Body-Malapel M, et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006;440:233-236
32. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991;9:457-492
33. Jurk M, Heil F, Vollmer J, et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002;3:499.
34. Schon M, Schon MP. The antitumoral mode of action of imiquimod and other imidazoquinolines. Curr Med Chem 2007;14:681-687
35. Gunzer M, Riemann H, Basoglu Y, et al. Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion. Blood 2005;106:2424-2432
36. Gorski KS, Waller EL, Bjornton-Severson J, et al. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int Immunol 2006;18:1115-1126
37. Guruvayoorappan C. Tumor versus tumor-associated macrophages: how hot is the link? Integr Cancer Ther 2008;7:90-95
38. Yuan A, Chen JJ, Yang PC. Pathophysiology of tumor-associated macrophages. Adv Clin Chem 2008;45:199-223.
39. Smith KJ, Hamza S, Skelton H. Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern. Clin Exp Dermatol 2004;29:505-512
40. van Lent PL, Blom AB, Grevers L, Sloetjes A, van den Berg WB. Tolllike receptor 4 induced FcaγR expression potentiates early onset of joint inflammation and cartilage destruction during immune complex arthritis: Toll-like receptor 4 largely regulates FcγR expression by interleukin 10. Ann Rheum Dis 2007;66:334-340
41. te Velde AA, de Waal MR, Huijbens RJ, de Vries JE, Figdor CG. IL-10 stimulates monocyte Fc γ R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-γ, IL-4, and IL-10. J Immunol 1992;149:4048-4052
42. van Roon J, Wijngaarden S, Lafeber FP, et al. Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc γ receptor expression on monocytes and responsiveness to immune complex stimulation. J Rheumatol 2003;30:648-651
43. Liu Y, Masuda E, Blank MC, et al. Cytokine-mediated regulation of activating and inhibitory Fc γ receptors in human monocytes. J Leukoc Biol 2005;77:767-776
44. Wijngaarden S, van de Winkel JG, Jacobs KM, et al. A shift in the balance of inhibitory and activating Fcaγ receptors on monocytes toward the inhibitory Fcaγ receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis. Arthritis Rheum 2004;50:3878-3887
45. Pricop L, Redecha P, Teillaud JL, et al. Differential modulation of stimulatory and inhibitory Fc γ receptors on human monocytes by Th1 and Th2 cytokines. J Immunol 2001;166:531-537
46. Houghton AN. Cancer antigens: immune recognition of self and altered self. J Exp Med 1994;180:1-4.
47. Hutchins JT, Kull FCJR, Bynum J, et al. Improved biodistribution, tumor targeting, and reduced immunogenicity in mice with a γ 4 variant of Campath-1H. Proc Natl Acad Sci U S A 1995;92:11980-11984
48. Lazar GA, Dang W, Karki S, et al. Engineered antibody Fc variants with enhanced effector function. Proc Natl Acad Sci U S A 2006;103:4005-4010